Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy

Published:2017-01 Issue:1 Volume:197 Page:109-114
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Wagner Andrew A.¹²,Cheng Philip J.³,Carneiro Arie⁴,Dovirak Ostap⁵,Khosla Arjun¹,Taylor Kimberly N.¹,Crociani Catrina M.¹,McAnally Kyle C.¹,Percy Andrew⁶,Dewey Lauren E.¹,Sanda Martin G.⁷,Chang Peter¹²

Affiliation:

1. Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts

2. Harvard Medical School, Boston, Massachusetts

3. Harvard Longwood Program in Urology, Boston, Massachusetts

4. Hospital Israelita Albert Einstein and ABC Medical School, São Paolo, Brazil

5. Virginia Beach, Virginia

6. Virginia Commonwealth University School of Medicine, Richmond, Virginia

7. Emory University School of Medicine, Atlanta, Georgia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer;Chang;J Urol,2011

2. Differing perceptions of quality of life in patients with prostate cancer and their doctors;Sonn;J Urol,2013

3. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure;Litwin;Med Care,1998

4. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer;Wei;Urology,2000

5. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors;Szymanski;Urology,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study;Clinical and Translational Radiation Oncology;2024-01

2. Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes;Cancer Medicine;2023-02-12

3. Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer;Frontiers in Oncology;2022-12-23

4. Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial;Current Oncology;2022-11-30

5. Creation and validation of the harmonized Arabic version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP);Arab Journal of Urology;2021-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3